I am investigating the hypothesis that Hu protein family members have non-redundant functions as negative regulators of the alternative splicing of neurofibromatosis type I (NF1) exon 23a. This research will help to determine the mechanisms behind how these splicing suppressors have diverged in function, and will also shed light on the mechanisms by which Hu proteins regulate splicing, which is not well understood. Preliminary data indicate that HuC is a strong suppressor and HuB a weak suppressor of NF1 exon 23a inclusion. In my project, I will investigate whether HuB and HuC vary in ability to regulate endogenous NF1 splicing in primary mouse cerebellar granule neurons. In addition, I will investigate the mechanism of the difference between HuB and HuC in splicing suppressor potency by performing in vitro splicing and spliceosome assembly assays. I will perform these assays using a novel system involving preparation of nuclear extract from mouse embryonic stem cells differentiated into neurons rather than from immortalized cell lines or whole tissues containing a heterogeneous mixture of cell types. Public Health Relevance: Alternative splicing is a process that is critical for many functions within the nervous system, such as neuronal development, and errors in alternative splicing can lead to disease, making it important to understand how the process is regulated. My study will help to elucidate the mechanism by which the Hu protein family regulates neurofibromatosis type I (NF1) exon 23a inclusion, a splicing event that is important for NF1 function and could possibly affect severity of NF1 disease. In addition, my studies will increase understanding of the molecular functions of the Hu proteins, which are associated with a disease called paraneoplastic syndrome.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31NS064724-01A1
Application #
7751612
Study Section
Special Emphasis Panel (ZRG1-F03A-F (20))
Program Officer
Fountain, Jane W
Project Start
2010-01-01
Project End
2012-02-29
Budget Start
2010-01-01
Budget End
2010-12-31
Support Year
1
Fiscal Year
2009
Total Cost
$39,922
Indirect Cost
Name
Case Western Reserve University
Department
Genetics
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Nguyen, Hieu T; Hinman, Melissa N; Guo, Xuan et al. (2017) Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice. Hum Mol Genet 26:3797-3807
Zhou, Hua-Lin; Hinman, Melissa N; Barron, Victoria A et al. (2011) Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proc Natl Acad Sci U S A 108:E627-35